Else Announces Voting Results – GuruFocus.com
VANCOUVER, British Columbia, June 30, 2022 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the “Company”) is pleased to announce that at its Annual General Meeting of Shareholders held on June 30, 2022, all resolutions submitted to shareholders were passed. At the meeting, shareholders approved the fixing of the number of directors at seven and the re-election of all nominees for the positions of management directors, as listed in the management proxy circular dated May 2022, to the Board of Directors to serve until the next Annual General Meeting. In addition, shareholders approved the reappointment of Kost Forer Gabbay & Kasierer, a member firm of Ernst & Young Global Limited, as the Company’s auditors.
A total of 42,112,902 or 40.19% of the issued and outstanding shares of the Company were represented at the Meeting. The election of directors was approved by a majority vote of shareholders as follows:
|Movements||vote for||Votes withheld|
|Hamutal Yitzhak||41,986,753||99.7%||126 149||0.3%|
|Uriel Kesler||41,991,753||99.71%||121 149||0.29%|
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean, plant-based food and nutrition products for infants, toddlers, children and adults. Its revolutionary plant-based, soy-free formula is an alternative to the dairy-based formula’s own ingredients. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked #1 Seller in the Baby & Toddler Formula category on Amazon. The company recently received the World Plant-Based Award for “Best Alternative Dairy Product” in New York City at the World Plant-Based Expo in late 2021. The holding company, Else Nutrition Holdings Inc., is a publicly traded company listed on the Toronto Stock Exchange. Stock Exchange under the symbol BABY and is listed on the US OTC Markets QX board under the symbol BABYF and on the Frankfurt Stock Exchange under the symbol 0YL. Else executives include executives from leading infant nutrition companies. Many members of Else’s advisory board have held senior positions at companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition companies, and some of them currently hold various positions in leading medical centers and academic institutes such as Boston Children’s Hospital. , Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and Brussels University Hospital, Belgium.
For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
For more information contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder and Director
ELSE Nutrition Holdings Inc.
E : [email protected]
Mr. Sokhie Puar, Senior Director of Else Nutrition
E-mail: [email protected]
Contact with Investor Relations:
Lytham Partners, LLC
Mr Ben Shamsian
New York | Phoenix
E : [email protected]
Such. : 646-829-9701
Toronto Stock Exchange
Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are generally identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements regarding the expected dates for the filing of the Company’s financial disclosure documents. These forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors that management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be accurate. Forward-looking statements made in this press release assume, among other things, the expectation that there will be no supply chain disruptions or failures as a result of COVID 19 and that the manufacturing agreement , brokerage and supply logistics with the Company does not end. Actual results may differ from the estimates, beliefs and assumptions expressed or implied by the forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.